Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Author: Helitra.com
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Kits Eyecare (TSX:KITS:CA) mentioned on Thursday that sure promoting shareholders have entered into an settlement with Canaccord Genuity as sole bookrunner to buy on a purchased…
Ensysce Biosciences announces $5M concurrent providing, shares fall Source: Seekingalpha
P3 Health Partners appoints Leif Pedersen as CFO Source: Seekingalpha
Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts Source: Seekingalpha
CareTrust REIT acquires two nursing facilities for $62.1M Source: Seekingalpha
Ekso Bionics prices $6M offering Source: Seekingalpha